The Sunshine Act refers to a U.S. federal law that aims to promote transparency and accountability in the relationships between healthcare providers, such as doctors and hospitals, and pharmaceutical manufacturers and medical device companies. The official name of the law is the "Physician Payments Sunshine Act," and it is a provision of the Affordable Care Act (Obamacare), enacted in 2010.
The primary goal of the Sunshine Act is to disclose financial relationships and payments between healthcare providers and manufacturers. This includes payments, gifts, meals, travel expenses, and other compensation that could potentially influence medical decisions or prescriptions. By making this information publicly available, the law aims to prevent conflicts of interest and increase transparency within the healthcare industry.
Under the Sunshine Act, applicable manufacturers of drugs, devices, biologicals, and medical supplies are required to report certain payments and transfers of value made to covered recipients, which typically include physicians and teaching hospitals. The reported information is then compiled into a publicly accessible database called the Open Payments Program, which provides a searchable resource for patients, researchers, and the public to understand the financial relationships between healthcare providers and industry entities.
It's important to note that regulations and details related to the Sunshine Act may change, and specific requirements may vary over time. Always refer to the most current and relevant sources, such as official government websites or legal experts, for the latest information on this topic.